Quilvest Capital Partners Exits Tri-Imaging Solutions, an Integrated Provider of Parts and Services for Diagnostic Imaging Equipment
January 14th, 2026 – Quilvest Capital Partners ("Quilvest") is pleased to announce it has exited its investment in Tri-Imaging Solutions (“TIS” or the “Company”), in a transaction with DirectMed Imaging ("DirectMed"), which is backed by Frazier Healthcare Partners ("Frazier").
Based in Madison, Tennessee, TIS is a technology-enabled provider of parts and services to the diagnostic imaging equipment maintenance and repair market.
Throughout its hold period, Quilvest supported management in executing a multi-pronged value creation plan to drive growth by (i) growing contracted revenue offerings, (ii) expanding into the provision of services in addition to its core parts offerings, (iii) bolstering corporate infrastructure with key leadership hires and (iv) building out the Company’s proprietary technology platforms.
Jared Nagae, Managing Director at Quilvest, said: "Our investment in TIS and partnership with Eric Wright and the management team have been greatly successful. We are extremely proud to have partnered with TIS and of the growth the Company achieved over the course of our partnership. "
Eric Wright, CEO of TIS, said: "Quilvest has been a great partner for TIS over the last six years. Their focus on investing in and supporting the growth ambitions of founder-owned services businesses proved to be invaluable, and their partnership helped position the Company for its next chapter of growth."
Ben Sass, Partner and Head of U.S. Buyouts at Quilvest, added: “Quilvest’s partnership with Tri- Imaging is a great representation of our investment strategy. Through substantial investment in tech-enablement and infrastructure, Tri-Imaging truly differentiated itself and transformed its sector. We wish Eric, the team and its new partners nothing but continued success.”
Harris Williams acted as the financial advisor, and Greenberg Traurig, P.A. acted as the legal advisor to the Company and Quilvest.